Form 4 for ICE Intercontinental Exchange
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-19 · accession 0000950170-25-075231 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-05-20 | 2025-05-19 | ICE | King Elizabeth Kathryn | CRO, Gbl Head of Clearing | S - Sale+OE | $175.46 | -16.8K | 23.4K | -42% | -$2.94M |
| DT | 2025-05-20 | 2025-05-19 | ICE | King Elizabeth Kathryn | CRO, Gbl Head of Clearing | M - OptEx | $92.63 | +10.9K | 33.2K | +49% | +$1.01M |
| DT | 2025-05-20 | 2025-05-19 | ICE | King Elizabeth Kathryn | CRO, Gbl Head of Clearing | M - OptEx | $0.00 | -10.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Holding | 2025-05-19 | S | D | 7,030 | $176.08 | 16,407 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 15, 2025. (F3) The price range for the aggregate amount sold by the direct holder is $175.50 - $176.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. (F4) The common stock number referred in Table I is an aggregate number and represents 7,513 shares of common stock, 3,141 unvested restricted stock units ("RSUs"), and 5,753 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. (F5) The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year EBITDA PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. |
| 2 | Common | Common Stock Holding | 2025-05-19 | M | A | 10,930 | $92.63 | 33,175 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 15, 2025. |
| 3 | Common | Common Stock Holding | 2025-05-19 | S | D | 9,738 | $175.02 | 23,437 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 15, 2025. (F2) The price range for the aggregate amount sold by the direct holder is $174.45 - $175.41. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Employee Stock Option (right to buy) Holding | 2025-05-19 | M | D | 10,930 | $0.00 | 0 | D | $92.63 · — to 2030-02-07 | 10,930 Common Stock | (F6) These options are fully vested. |